Literature DB >> 21768698

Esophageal cancer: 5-year survival rate at south-east of Caspian sea of northern Iran.

Mohammad Hussin Taziki1, Siamak Rajaee, Naser Behnampour, Massoud Tadrisee, Azad Reza Mansourian.   

Abstract

BACKGROUND: Locating at southern margin of Caspian sea and Asian esophagus cancer cordon Golestan state is one of the most common sites of this cancer.
OBJECTIVE: This study designed to evaluate the 5-years survival rate of esophagus cancer.
MATERIALS AND METHODS: 55 patients with esophagus cancer diagnosed by pathologic examination, age, gender, type of tumor, clinical manifestation on the time of tumor metastases, treatment and patient survival time studied. The collecting data were analyzed by SPSS 11.5, and life table and Kaplan Meier methods were applied.
RESULTS: 55 patients studied included 11 females and 44 males respectively with average survival life time of 12.8 months for the 5-year survival rate for patients diagnosed at early stage was 0.025, patients with systemic symptoms such as weight loss was 0.00. Far metastases adverse effect on highest survivals was observed among patients who underwent surgery; the survival rate for such patients was about 0.014.
CONCLUSIONS: Esophageal cancer is high in southern margin of Caspian Sea, it is suggested to design studies to find the probable risk factors and the screening tests for on-time diagnosis.

Entities:  

Mesh:

Year:  2011        PMID: 21768698     DOI: 10.4103/0973-1482.82923

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  4 in total

Review 1.  Risk of pancreatic cancer in breast cancer families from the breast cancer family registry.

Authors:  Evelina Mocci; Roger L Milne; Elena Yuste Méndez-Villamil; John L Hopper; Esther M John; Irene L Andrulis; Wendy K Chung; Mary Daly; Saundra S Buys; Nuria Malats; David E Goldgar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-01       Impact factor: 4.254

2.  Cytotoxic effect of rosemary extract on gastric adenocarcinoma (AGS) and esophageal squamous cell carcinoma (KYSE30) cell lines.

Authors:  Neamat Karimi; Jalil Rashedi; Behroz Mahdavi Poor; Sepideh Arabi; Maryam Ghorbani; Nahideh Tahmasebpour; Mohammad Asgharzadeh
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017

3.  The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma.

Authors:  Wenjing Zhang; Yaxing Zhou; Chao Li; Shanshan Xu; Mengyan Li; Wenying Liu; Yuqing Ma; Hui Wang
Journal:  Anal Cell Pathol (Amst)       Date:  2020-12-11       Impact factor: 2.916

Review 4.  Immunotherapy resistance in esophageal cancer: Possible mechanisms and clinical implications.

Authors:  Pinhao Fang; Jianfeng Zhou; Zhiwen Liang; Yushang Yang; Siyuan Luan; Xin Xiao; Xiaokun Li; Hanlu Zhang; Qixin Shang; Xiaoxi Zeng; Yong Yuan
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.